Newsletter | June 3, 2026

06.03.26 -- FDA Approval Is Not Synonymous With Commercial Success

DECENTRALIZED TRIALS

Forget More Clinical Tech, We Need More Adoption

At SCOPE Summit, Craig Lipset shared a blunt assessment of clinical trial innovation: the tools exist, regulators are engaged, and digital approaches offer clear quality advantages — yet adoption remains the industry’s biggest hurdle. Lipset argues progress will depend less on new technology and more on scaling what already works.

Decentralized Trials: Direct-To-Patient, Pharmacy-Led Solutions

Pharmacy-led DTP models cut site burden, improve inventory control, and expand trial access. Learn how to optimize your decentralized trial supply chain for compliance and patient outcomes.

At-Home Clinical Trials: When At-Home Ophthalmic Exams Make Sense

At-home ophthalmic exams in clinical trials improve patient accessibility, reduce site burden, and maintain data integrity, enabling decentralized research without sacrificing quality or compliance.

TRIAL MANAGEMENT

Collaboration Isn't Sexy. That's Kind of the Point.

SCRS’s Collaborate Forward playbook isn’t about reinventing clinical trials; it’s about fixing how people work together. Based on real-world examples, the initiative shows how small, practical changes in collaboration are already improving study startup, site relationships, and operational performance.

Reminder: FDA Approval Is Not Synonymous With Commercial Success

Life sciences expert Rena Roseberg, Ph.D., explains why research and commercial teams cannot work in isolation, and shares best practices for developing therapeutics with clear commercial viability.

The Anatomy Of RTSM Change Requests

Stop letting rigid RTSM architectures delay your clinical trial. Learn how modern, configurable platforms eliminate engineering bottlenecks to accelerate mid-study change requests.

Optimizing The Path From First-In-Human To Proof-Of-Concept

By collapsing the gaps between manufacturing and clinical trials and integrating these functions into a unified system, teams can adjust formulations in real-time and accelerate timelines.

Future Predictions For Clinical Technologies

In 2025, sponsors are prioritizing configurable, interoperable solutions that integrate seamlessly across IRT, eCOA, CTMS, eConsent, and supply chain systems.

Radiopharmaceuticals: A Transformative Force In Oncology

Explore how the integration of diagnostics and targeted radiation is transforming oncology, offering new pathways for overcoming treatment resistance and accelerating clinical development.

Innovative Dermatological Assessments For Early Drug Development

Our dermatology studies provide results that are more than skin deep. Our dermatology research also facilitates drug development that extends beyond the skin to encompass immunology and endocrinology.

Easy-To-Use Analytics Platform For Vendor Selection And Management

Centralize RFPs, budgets, and vendor data so you can select the right partners, manage change orders, and keep your studies on track.

RTSM And IRT Solutions For Clinical Trials

Global leader in RTSM/IRT, helping sponsors and CROs speed study start-up, optimize supply, and manage complex trials with confidence.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Wednesday edition of the Clinical Leader newsletter, focusing on Decentralized Trials and Trial Management. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: